An underlying inflammatory nature of SSc as a progressive disease is undisputed, and recent data indicate that pro-inflammatory cytokines are involved in the development of PAH [44,48], such as interleukin-6 (IL-6) [49]. Here, IL6 is linked to systemic sclerosis.